SciSparc News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

26.09.24	SciSparc Inks Non-binding LOI To Sell Its Entire Ownership Interest In MitoCareX Bio (RTTNews)
23.09.24	SciSparc Says FDA OKs Initiation Of Phase IIb Clinical Trial For SCI-110 To Treat Tourette Syndrome (RTTNews)
15.08.24	SciSparc Soars In Pre-market After Updating Merger With AutoMax Motors (RTTNews)
22.11.23	SciSparc Reveals Non-Binding LoI To Merge With Vehicle Importer In Israel (RTTNews)
16.11.23	Pre-market Movers: AUGX, BIVI, CHSN, VLD, FLGC… (RTTNews)
01.11.23	Pre -market Movers: CLLS, PAYC, WE, IRIX, GDEV… (RTTNews)
29.09.23	SciSparc Initiates SCI-210 Clinical Trial In Pediatrics With Autism Spectrum Disorder (RTTNews)
23.06.22	Pre-market Movers: BOXD, NN, ARR, SPRC, TOP… (RTTNews)
27.05.22	Pre-market Movers: IOVA, MRTX, BIG, GPS, PMVP… (RTTNews)
26.05.22	Pre-market Movers: NTNX, WKME, SNOW, ISPC, NNVC… (RTTNews)
25.05.22	Pre-market Movers: VRCA, CMRA, WEN, SPRC, NEGG… (RTTNews)
29.06.20	Therapix Biosciences Raises $2.6 Million in Private Placement (PR Newswire)
21.12.18	Therapix Biosciences Terminates FSD Acquisition Letter of Intent (PR Newswire)
03.12.18	Therapix Biosciences Reports Third Quarter 2018 Financial Results and Provides Business Update (PR Newswire)
24.10.18	Therapix Biosciences Signs Binding LOI to be Acquired by FSD Pharma for $48 Million, to Create Medical Cannabis Industry Innovator (PR Newswire)
17.07.18	Therapix Biosciences Announces Positive Data From Recent Pre-clinical Studies for its Drug Candidate THX-160 for Treatment of Pain (PR Newswire)
07.11.17	Therapix to Present at and Attend Investor Conferences in London (PR Newswire)
30.10.17	Therapix Biosciences Initiates Non-clinical Studies for its Antibacterial Program in Collaboration With the Weizmann Institute of Science and Tel Aviv Sourasky Medical Center (PR Newswire)
05.04.17	Therapix Signs Exclusive License Agreement with Yissum for Nasal Drug Delivery Technology (PR Newswire)
03.04.17	Therapix Biosciences Ltd. Announces Full Exercise of Underwriters' Over-Allotment Option (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V